Modulation by the hypocretinergic/orexinergic neurotransmission system in sleep-wakefulness cycle states;El sistema de neurotransmisión hipocretinérgico/ orexinérgico en la regulación de los estados de vigilia y sueño

Revista de Neurologia

Volumn 45, Issue 8, 2007, Pages 482-490

  Del Cid Pellitero, E ^a   Garzón García, Miguel ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Hypocretin; Hypothalamus; Narcolepsy; Orexin; REM; Sleep; Wakefulness

Indexed keywords

ADRENERGIC TRANSMISSION; BRAIN FUNCTION; CHOLINERGIC TRANSMISSION; DOPAMINERGIC SYSTEM; DREAM; ELECTROENCEPHALOGRAPHY; HUMAN; NARCOLEPSY; NEUROTRANSMISSION; NORADRENERGIC SYSTEM; REM SLEEP; RETICULAR FORMATION; REVIEW; SEROTONINERGIC SYSTEM; THERMOREGULATION;

EID: 37349129636     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.4508.2006014     Document Type: Review

References (80)

1. Bayer L, Serafin M, Eggermann E, Saint-Mieux B, Machard D, Jones BE, et al. Exclusive postsynaptic action of hypocretin-orexin on sublayer 6b cortical neurons. J Neurosci 2004; 24: 6760-4.
2. Saper CB, Chou TC, Scammell TE. The sleep switch: hypothalamic control of sleep and wakefulness. Trends Neurosci 2001; 24: 726-31.
3. Lee GM, Hassani OK, Jones BE. Discharge of identified orexin/hypocretin neurons across the sleep-waking cycle. J Neurosci 2005; 25: 6716-20.
4. De Lecea L, Kilduff TS, Peyron C, Gao X, Foye PE, Danielson PE, et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A 1998; 95: 322-7.
5. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G-protein. Coupled receptors that regulate feeding behaviour. Cell 1998; 92: 573-85.
6. Peyron C, Tighe DK, Van den Pol AN, De Lecea L, Heller HC, Sutcliffe JG, et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 1998; 18: 9996-10015.
7. Núñez A, Moreno-Balandrán ME, Rodrigo-Angulo ML, Garzón M, De Andrés I. Relationship between the perifornical hypothalamic area and oral pontine reticular nucleus in the rat. Possible implication of the hypocretinergic projection in the control of rapid eye movement sleep. Eur J Neurosci 2006; 24: 2834-42.
8. Chen CT, Dun SL, Kwok EH, Dun NJ, Chang JK. Orexin A-like immunoreactivity in the rat brain. Neurosci Lett 1999; 260: 161-4.
9. Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 2000; 355: 39-40.
10. Sakurai T. Orexins and orexin receptors: implication in feeding behaviour. Regul Pept 1999; 85: 25-30.
11. Johren O, Neidert SJ, Kummer M, Dendorfer A, Dominiak P. Preproorexin and orexin receptor mRNAs are differentially expressed in peripheral tissues of male and female rats. Endocrinology 2001; 142: 3324-31.
12. Trivedi P, Yu H, MacNeil DJ, Van der Ploeg LH, Guan XM. Distribution of orexin receptor mRNA in the rat brain. FEBS Lett 1998; 438: 71-5.
13. Kilduff TS, Peyron C. The hypocretin/orexin ligand-receptor system: implications for sleep and sleep disorders. Trends Neurosci 2000; 23: 359-65.
14. Van den Pol AN, Gao XB, Obrietan K, Kilduff TS, Belousov AB. Presynaptic and postsynaptic actions and modulation of neuroendocrine neurons by a new hypothalamic peptide, hypocretin/orexin. J Neurosci 1998; 18: 7962-71.
15. De Lecea L, Sutcliffe JG, Fabre V. Hypocretins/orexins as integrators of physiological information: lessons from mutant animals. Neuropeptides 2002; 36: 85-95.
16. Greco MA, Shiromani PJ. Hypocretin receptor protein and mRNA expression in the dorsolateral pons of rats. Mol Brain Res 2001; 88: 176-82.
17. Horvath TL, Peyron C, Diano S, Ivanov A, Aston-Jones G, Kilduff TS, et al. Hypocretin (orexin) activation and synaptic innervations of the locus coeruleus noradrenergic system. J Comp Neurol 1999; 415: 145-59.
18. Hagan JJ, Leslie RA, Patel S, Evans ML, Wattam TA, Holmes S, et al. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc Natl Acad Sci U S A 1999; 96: 10911-6.
19. Van den Pol AN. Hypothalamic hypocretin (orexin): robust innervation of the spinal cord. J Neurosci 1999; 19: 3171-82.
20. Mobarakeh JI, Takahashi K, Saturada S, Nishino S, Watanabe H, Kato M, et al. Enhanced antinociception by intracerebroventricularly and intrathecally-administered orexin A and B (hypocretin-1 and -2) in mice. Peptides 2005; 26: 767-77.
21. Von Economo C. Sleep as a problem of localization. J Nerv Ment Dis 1930; 71: 249-59.
22. Nauta WGH. Hypothalamic regulation of sleep in rat. An experimental study. J Neurophysiol 1946; 9: 285-316.
23. Bremer F. Cervau isolé et physiologie du sommeil. C R Soc Biol 1935; 118: 1235-41.
24. Moruzzi G, Magoun HW. Brainstem reticular formation an activation of the EEG. EEG Clin Neurophysiol 1949; 1: 455-73.
25. Hobson JA, McCarley RW, Wyzinski PW. Sleep cycle oscillation: reciprocal discharge by to brainstem neuronal groups. Science 1975; 189: 55-8.
26. Reinoso-Suárez F, Llamas A. Conexiones aferentes a la corteza frontal desde tegmento pontomesencefálico (locus coeruleus, rafe, sustancia negra) en la rata. An Anat 1975; 24: 337-50.
27. Reinoso-Suárez F, De Andrés I, Rodrigo-Angulo ML, Garzón M. Brain structures and mechanisms involved in the generation of REM sleep. Sleep Med Rev 2001; 5: 63-7.
28. Reinoso-Suárez F. Neurobiología del despertar y la vigilia. An R Acad Nac Med 1997; 114: 249-64.
29. Reinoso-Suárez F. Neurobiología del sueño. Rev Med Univ Navarra 2005; 49: 10-7.
30. Berridge CW, Foote SL. Effects of locus coeruleus activation on electroencephalographic activity in neocortex and hippocampus. J Neurosci 1991; 11: 3135-45.
31. Mignot E, Taheri S, Nishino S. Sleeping with the hypothalamus: emerging therapeutic targets for sleep disorders. Nat Neurosci Suppl 2002; 5: 1071-5.
32. Bayer L, Eggermann E, Serafin M, Saint-Mleux B, Machard D, Jones B, et al. Orexins (hypocretins) directly excite tuberomammillary neurons. Eur J Neurosci 2001; 14: 1571-5.
33. Eriksson KS, Sergeeva O, Brown RE, Haas HL. Orexin/hypocretin excites the histaminergic neurons of the tuberomammillary nucleus. J Neurosci 2001; 21: 9273-9.
34. Jones BE. Activity, modulation and role of basal forebrain cholinergic neurons innervating the cerebral cortex. Prog Brain Res 2004; 145: 157-69.
35. Brown RE, Sergeeva O, Eriksson KS, Haas HL. Orexin A excites serotonergic neurons in the dorsal raphe nucleus of the rat. Neuropharmacology 2001; 40: 457-9.
36. Martínez-Rodríguez JE, Santamaría J. Narcolepsia e hipersomnia idiopática. Rev Med Univ Navarra 2005; 49: 35-40.
37. Salín-Pascual RJ. Hipocretinas y adenosina en la regulación del sueño. Rev Neurol 2004; 39: 354-8.
38. Kiyashchenko LI, Mileykovskiy BY, Maidment N, Lam HA, Wu MF, John J, et al. Release of hypocretin (orexin) during waking and sleep states. J Neurosci 2002; 22: 5282-6.
39. Singewald N, Philippu A. Release of neurotransmitters in the locus coeruleus. Prog Neurobiol 1998; 56: 237-67.
40. Loughlin SE, Foote SL, Grzanna R. Efferent projections of nucleus locus coeruleus: morphologic subpopulations have different efferent targets. Neuroscience 1986; 18: 307-19.
41. Bourgin P, Huitron-Resendiz S, Spier AD, Fabre V, Morte B, Criado JR, et al. Hypocretin-1 modulates rapid eye movement sleep through activation of LC neurons. J Neurosci 2000; 20: 7760-5.
42. Vertes. A PHA-L analysis of ascending projections of the dorsal raphe nucleus in the rat. J Comp Neurol 1991; 313: 643-68.
43. Puig MV, Artigas F, Celada P. Modulation of activity of pyramidal neurons in rat prefrontal cortex by raphe stimulation in vivo: involvement of serotonin and GABA. Cereb Cortex 2005; 15: 1-14.
44. Puig MV, Celada P, Artigas F. Control serotoninérgico de la corteza prefrontal. Rev Neurol 2004; 39: 539-47.
45. Lee HS, Park SH, Song WC, Waterhouse BD. Retrograde study of hypocretin-1 (orexin-A) projections to subdivisions of the dorsal raphe nucleus in the rat. Brain Res 2005; 1059: 35-45.
46. Tao R, Ma Z, McKenna JT, Thakkar MM, Winston S, Strecker RE, et al. Differential effect of orexins (hypocretins) on serotonin release in the dorsal and median raphe nuclei of freely behaving rats. Neuroscience 2006; 141: 1101-5.
47. Siegel JM. The neurotransmitters of sleep. J Clin Psychiatry 2004; 65 (Suppl 16): 4-7.
48. Korotkova TM, Eriksson KS, Haas HL, Brown RE. Selective excitation of GABAergic neurons in the sustantia nigra of the rat by orexin/hypocretin in vitro. Regul Pept 2002; 104: 83-9.
49. Wang QP, Guan JL, Matsuoka T, Hirayana Y, Shioda S. Electron microscopic examination of the orexin immunoreactivity in the dorsal raphe nucleus. Peptides 2003; 24: 925-30.
50. Vanni-Mercier G, Gigout S, Debilly G, Lin JS. Waking selective neurons in the posterior hypothalamus and their response to histamine H3-receptor ligands: an electrophysiological study in freely moving cats. Behav Brain Res 2003; 144: 227-41.
51. Ko EM, Estabrooke IV, McCarthy M, Scammell TE. Wake-related activity of tuberomammillary neurons in rats. Brain Res 2003; 992: 220-6.
52. Huang ZL, Qu WM, Li WD, Mochizuki T, Eguchi N, Watanabe T, et al. Arousal effect of orexin A de pends on activation of the histaminergic system. Proc Natl Acad Sci U S A 2001; 98: 9965-70.
53. Nishino S, Fujiki N, Ripley B, Sakurai E, Kato M, Watanabe T, et al. Decreased brain histamine content in hypocretin/orexin receptor-2 mutated narcoleptic dogs. Neurosci Lett 2001; 313: 125-8.
54. Sherin JE, Elmquist JK, Torrealba F, Saper CB. Innervation of histaminergic tuberomammillary neurons by GABAergic and galaninergic neurons in the ventrolateral preoptic nucleus of the rat. J Neurosci 1998; 18: 4705-21.
55. Marcus JN, Aschkenasi CJ, Lee CE, Chemelli RM, Saper CB, Yanagisawa M, et al. Differential expression of orexin receptors 1 and 2 in the rat brain. J Comp Neurol 2001; 435: 6-25.
56. Vittoz NM, Berridge CW. Hypocretin/orexin selectively increases dopamine efflux within the prefrontal cortex: involvement of the ventral tegmental area. Neuropsychopharmacology 2006; 31: 384-95.
57. Korotkova TM, Sergeeva OA, Eriksson KS, Haas HL, Brown RE. Excitation of ventral tegmental area dopaminergic and nondopaminergic neurons by orexins/hypocretins. J Neurosci 2003; 23: 7-11.
58. Wu M, Zaborszky L, Hajszan T, Van den Pol AN, Alreja M. Hypocretin/orexin innervation and excitation of identified septohippocampal cholinergic neurons. J Neurosci 2004; 24: 3527-36.
59. Eggermann E, Serafin M, Bayer L, Machard D, Saint-Mleux B, Jones BE, et al. Orexins/hypocretins excite basal forebrain cholinergic neurones. Neuroscience 2001; 108: 177-81.
60. Thakkar MM, Ramesh V, Strecker RE, McCarley RW. Microdialysis perfusion of orexin-A in the basal forebrain increases wakefulness in freely behaving rats. Arch Ital Biol 2001; 139: 313-28.
61. Fadel J, Pasumarthi R, Reznikov LR. Stimulation of cortical acetylcholine release by orexin A. Neuroscience 2005; 130: 541-7.
62. Burlet S, Tyler CJ, Leonard CS. Direct and indirect excitation of laterodorsal tegmental neurons by hypocretin/orexin peptides: implications for wakefulness and narcolepsy. J Neurosci 2002; 22: 2862-72.
63. Steriade M, Datta S, Pare D, Oakson G, Curro Dossi RC. Neuronal activities in brain-stem cholinergic nuclei related to tonic activation processes in thalamocortical systems. J Neurosci 1990; 10: 2541-59.
64. Xi MC, Morales FR, Chase MH. Effects on sleep and wakefulness of the injection of hypocretin-1 (orexin-A) into the laterodorsal tegmental nucleus of the cat. Brain Res 2001; 901: 259-64.
65. Moreno-Balandrán ME, Robayo OF, Garzón M, De Andrés I. Efectos de la orexina A en las fases del ciclo vigilia-sueño administrada a regiones colinoceptivas del tegmento pontino. Vigilia-Sueño 2004; 16: 91.
66. Lin L, Faraco J, Li R, Kadotani H, Rogers W, Lin X, et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 1999; 98: 365-76.
67. Chemelli RM, Willie JT, Sinton C, Elmquist J, Scammell TS, Lee C, et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 1999; 98: 437-51.
68. Van den Pol AN. Narcolepsy: neurodegenerative disease of the hypocretin system? Neuron 2000; 27: 415-8.
69. Thannickal TC, Moore RY, Nienhuis R, Ramanathan L, Gulyani S, Aldrich M, et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron 2000; 27: 469-74.
70. Peyron C, Faraco J, Rogers W, Ripley B, Overeem S, Charnay Y, et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 2000; 6: 991-7.
71. Mignot E, Lammers GJ, Ripley B, Okun M, Nevsimalova S, Overeem S, et al. The role of cerebrospinal fluid hypocretin measurement in the diagnostic of narcolepsy and other hypersomnias. Arch Neurol 2002; 59: 1553-62.
72. Tafti M, Nishino S, Aldrich MS, Liao W, Dement WC, Mignot E. Major histocompatibility class II molecules in the CNS: increased microglial expression at the onset of narcolepsy in canine model. J Neurosci 1996; 16: 4588-95.
73. John J, Wu MF, Maidment NT, Lam HA, Boehmer LN, Patton M, et al. Developmental changes in CSF hypocretin-1 (orexin-A) levels in normal and genetically narcoleptic Doberman pinschers. J Physiol 2004; 560: 587-92.
74. Siegel JM, Nienhuis R, Gulyani S, Ouyang S, Wu MF, Mignot E, et al. Neuronal degeneration in canine narcolepsy. J Neurosci 1999; 19: 248-57.
75. Willie JT, Chemelli RM, Sinton CM, Tokita S, Williams SC, Kisanuki YY, et al. Distinct narcolepsy syndromes in orexin receptor-2 and orexin null mice: molecular genetic dissection of non-REM and REM sleep regulatory processes. Neuron 2003; 38: 715-30.
76. Mochizuki T, Crocker A, McCormack S, Yanagisawa M, Sakurai T, Scalmmell TE. Behavioral state instability in orexin knockout mice. J Neurosci 2004; 24: 6291-300.
77. Soffin EM, Gill CH, Brough SJ, Jerman JC, Davies C. Pharmacological characterization of the orexin receptor subtype mediating postsynaptic excitation in the rat dorsal raphe nucleus. Neuropharmacology 2004; 46: 1168-76.
78. McCormick DA. Neurotransmitter actions in the thalamus and cerebral cortex and their role in neuromodulation of thalamocortical activity. Prog Neurobiol 1992; 39: 337-88.
79. Abrahamson EE, Leak RK, Moore RY. The suprachiasmatic nucleus projects to posterior hypothalamic arousal systems. NeuroReport 2001; 12: 435-40.
80. Broughton R, Krupa S, Boucher B, Rivers M, Mullington J. Impaired circadian waking arousal in narcolepsy-cataplexy. Sleep Res Online 1998; 1: 159-65.